Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$324.75
2.730.85%
At close: -
$324.75
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Insulet Analyst Ratings and Price Targets | NASDAQ:PODD | Benzinga
Insulet Corp has a consensus price target of $299.42 based on the ratings of 27 analysts. The high is $355 issued by Citigroup on February 21, 2025. The low is $184 issued by Leerink Partners on October 16, 2023. The 3 most-recent analyst ratings were released by Wolfe Research, Oppenheimer, and Barclays on May 13, 2025, May 9, 2025, and April 30, 2025, respectively. With an average price target of $313.33 between Wolfe Research, Oppenheimer, and Barclays, there's an implied -3.52% downside for Insulet Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wolfe Research
Oppenheimer
Barclays
RBC Capital
Citigroup
1calculated from analyst ratings
Analyst Ratings for Insulet
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/13/2025 | Buy Now | 7.78% | Wolfe Research | Mike Polark67% | → $350 | Upgrade | Peer Perform → Outperform | Get Alert |
| 05/09/2025 | Buy Now | -0.23% | Oppenheimer | Steven Lichtman63% | $312 → $324 | Maintains | Outperform | Get Alert |
| 04/30/2025 | Buy Now | -18.09% | Barclays | Matt Miksic67% | $234 → $266 | Maintains | Equal-Weight | Get Alert |
| 04/29/2025 | Buy Now | — | Wolfe Research | Mike Polark67% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 03/06/2025 | Buy Now | 4.7% | RBC Capital | Shagun Singh57% | → $340 | Initiates | → Outperform | Get Alert |
| 02/21/2025 | Buy Now | 9.31% | Citigroup | Joanne Wuensch75% | $310 → $355 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 1% | Raymond James | Jayson Bedford68% | $294 → $328 | Reiterates | Outperform → Outperform | Get Alert |
| 02/21/2025 | Buy Now | -9.78% | Stifel | Mathew Blackman63% | $245 → $293 | Maintains | Hold | Get Alert |
| 02/21/2025 | Buy Now | -4.54% | Piper Sandler | Matt O'Brien52% | $285 → $310 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | -0.85% | Wells Fargo | Lawrence Biegelsen48% | $305 → $322 | Maintains | Overweight | Get Alert |
| 02/21/2025 | Buy Now | -0.23% | Canaccord Genuity | Kyle Rose68% | $304 → $324 | Maintains | Buy | Get Alert |
| 01/03/2025 | Buy Now | -0.23% | TD Cowen | Joshua Jennings55% | $264 → $324 | Maintains | Buy | Get Alert |
| 12/12/2024 | Buy Now | 1.62% | JP Morgan | Robbie Marcus63% | $280 → $330 | Maintains | Overweight | Get Alert |
| 12/11/2024 | Buy Now | -4.54% | Citigroup | Joanne Wuensch75% | $283 → $310 | Maintains | Buy | Get Alert |
| 12/11/2024 | Buy Now | -6.08% | Wells Fargo | Lawrence Biegelsen48% | $290 → $305 | Maintains | Overweight | Get Alert |
| 12/09/2024 | Buy Now | -6.39% | Canaccord Genuity | William Plovanic63% | $269 → $304 | Maintains | Buy | Get Alert |
| 11/11/2024 | Buy Now | -27.94% | Barclays | Matt Miksic67% | $220 → $234 | Maintains | Equal-Weight | Get Alert |
| 11/11/2024 | Buy Now | -2.39% | Morgan Stanley | Patrick Wood53% | $234 → $317 | Maintains | Overweight | Get Alert |
| 11/08/2024 | Buy Now | -16.86% | BTIG | Marie Thibault66% | $260 → $270 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | -7.62% | Bernstein | Lee Hambright70% | → $300 | Initiates | → Outperform | Get Alert |
| 10/14/2024 | Buy Now | -19.94% | Raymond James | Jayson Bedford68% | $213 → $260 | Maintains | Outperform | Get Alert |
| 10/14/2024 | Buy Now | -19.94% | BTIG | Marie Thibault66% | $250 → $260 | Maintains | Buy | Get Alert |
| 10/01/2024 | Buy Now | -15.32% | Citigroup | Joanne Wuensch75% | $250 → $275 | Maintains | Buy | Get Alert |
| 09/25/2024 | Buy Now | -17.17% | Canaccord Genuity | William Plovanic63% | $236 → $269 | Maintains | Buy | Get Alert |
| 09/17/2024 | Buy Now | -12.24% | Piper Sandler | Matt O'Brien52% | $230 → $285 | Maintains | Overweight | Get Alert |
| 08/12/2024 | Buy Now | -32.26% | Barclays | Matt Miksic67% | $200 → $220 | Maintains | Equal-Weight | Get Alert |
| 08/09/2024 | Buy Now | -23.02% | BTIG | Marie Thibault66% | $270 → $250 | Maintains | Buy | Get Alert |
| 08/09/2024 | Buy Now | -31.33% | UBS | Matthew Taylor69% | $211 → $223 | Maintains | Neutral | Get Alert |
| 07/23/2024 | Buy Now | -27.94% | Canaccord Genuity | William Plovanic63% | $234 → $234 | Maintains | Buy | Get Alert |
| 06/10/2024 | Buy Now | — | OTR Global | — | — | Downgrade | Positive → Mixed | Get Alert |
| 05/30/2024 | Buy Now | -27.64% | Redburn Atlantic | Issie Kirby31% | → $235 | Initiates | → Buy | Get Alert |
| 05/13/2024 | Buy Now | -38.41% | Barclays | Matt Miksic67% | $213 → $200 | Maintains | Equal-Weight | Get Alert |
| 05/10/2024 | Buy Now | -27.94% | Canaccord Genuity | Kyle Rose68% | $226 → $234 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | -34.41% | Raymond James | Jayson Bedford68% | $218 → $213 | Maintains | Outperform | Get Alert |
| 05/10/2024 | Buy Now | -19.94% | Jefferies | Matthew Taylor69% | $255 → $260 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | -38.41% | Wolfe Research | Mike Polark67% | → $200 | Upgrade | Peer Perform → Outperform | Get Alert |
| 02/26/2024 | Buy Now | -34.41% | Barclays | Matt Miksic67% | $214 → $213 | Maintains | Equal-Weight | Get Alert |
| 02/23/2024 | Buy Now | -29.18% | Piper Sandler | Matt O'Brien52% | $250 → $230 | Maintains | Overweight | Get Alert |
| 02/23/2024 | Buy Now | -30.72% | JP Morgan | Robbie Marcus63% | $190 → $225 | Maintains | Overweight | Get Alert |
| 02/05/2024 | Buy Now | -35.95% | Stifel | Mathew Blackman63% | $163 → $208 | Maintains | Hold | Get Alert |
| 12/21/2023 | Buy Now | -26.71% | Baird | Jeff Johnson77% | $180 → $238 | Upgrade | Neutral → Outperform | Get Alert |
| 12/04/2023 | Buy Now | -27.94% | Morgan Stanley | Patrick Wood53% | $185 → $234 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/03/2023 | Buy Now | -23.02% | Piper Sandler | Matt O'Brien52% | $325 → $250 | Maintains | Overweight | Get Alert |
| 10/17/2023 | Buy Now | -50.12% | JP Morgan | Robbie Marcus63% | $325 → $162 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | -43.34% | Leerink Partners | Mike Kratky66% | → $184 | Initiates | → Outperform | Get Alert |
| 10/02/2023 | Buy Now | -26.1% | Jefferies | Matthew Taylor69% | $260 → $240 | Upgrade | Hold → Buy | Get Alert |
| 09/29/2023 | Buy Now | -43.03% | Morgan Stanley | Patrick Wood53% | $208 → $185 | Maintains | Equal-Weight | Get Alert |
| 09/15/2023 | Buy Now | -29.79% | Raymond James | Jayson Bedford68% | $299 → $228 | Maintains | Outperform | Get Alert |
| 09/06/2023 | Buy Now | -33.8% | UBS | Matthew Taylor69% | $270 → $215 | Maintains | Neutral | Get Alert |
| 08/24/2023 | Buy Now | -9.16% | B of A Securities | Travis Steed58% | $365 → $295 | Maintains | Buy | Get Alert |
| 08/24/2023 | Buy Now | -35.95% | Morgan Stanley | Patrick Wood53% | $343 → $208 | Maintains | Equal-Weight | Get Alert |
| 08/21/2023 | Buy Now | -18.4% | Citigroup | Joanne Wuensch75% | $273 → $265 | Upgrade | Neutral → Buy | Get Alert |
| 08/21/2023 | Buy Now | -32.56% | Baird | Jeff Johnson77% | $320 → $219 | Downgrade | Outperform → Neutral | Get Alert |
| 08/10/2023 | Buy Now | -20.86% | Barclays | Matt Miksic67% | $329 → $257 | Maintains | Equal-Weight | Get Alert |
| 08/09/2023 | Buy Now | -7.62% | TD Cowen | Josh Jennings61% | $350 → $300 | Maintains | Outperform | Get Alert |
| 08/09/2023 | Buy Now | 0.08% | JP Morgan | Robbie Marcus63% | $365 → $325 | Maintains | Overweight | Get Alert |
| 08/09/2023 | Buy Now | -15.94% | Citigroup | Joanne Wuensch75% | $319 → $273 | Maintains | Neutral | Get Alert |
| 08/09/2023 | Buy Now | 1.62% | Wells Fargo | Lawrence Biegelsen48% | $375 → $330 | Maintains | Overweight | Get Alert |
| 08/09/2023 | Buy Now | -7.93% | Raymond James | Jayson Bedford68% | $350 → $299 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | -1.77% | Citigroup | Joanne Wuensch75% | $330 → $319 | Maintains | Neutral | Get Alert |
| 05/30/2023 | Buy Now | 5.62% | Morgan Stanley | Patrick Wood53% | → $343 | Assumes | → Equal-Weight | Get Alert |
| 05/08/2023 | Buy Now | 1.31% | Barclays | Matt Miksic67% | $292 → $329 | Maintains | Equal-Weight | Get Alert |
| 05/05/2023 | Buy Now | 5.62% | Morgan Stanley | Cecilia Furlong51% | $325 → $343 | Maintains | Equal-Weight | Get Alert |
| 05/05/2023 | Buy Now | 7.78% | Raymond James | Jayson Bedford68% | $334 → $350 | Maintains | Outperform | Get Alert |
| 05/05/2023 | Buy Now | 10.85% | Piper Sandler | Matt O'Brien52% | $340 → $360 | Maintains | Overweight | Get Alert |
| 05/05/2023 | Buy Now | 13.93% | Baird | Jeff Johnson77% | $350 → $370 | Maintains | Outperform | Get Alert |
| 04/20/2023 | Buy Now | 5.31% | Stifel | Mathew Blackman63% | $300 → $342 | Maintains | Hold | Get Alert |
| 04/17/2023 | Buy Now | 7.78% | BTIG | Ryan Zimmerman74% | $340 → $350 | Maintains | Buy | Get Alert |
| 02/24/2023 | Buy Now | 2.85% | Raymond James | Jayson Bedford68% | $320 → $334 | Maintains | Outperform | Get Alert |
| 02/24/2023 | Buy Now | 0.08% | Morgan Stanley | Cecilia Furlong51% | $320 → $325 | Maintains | Equal-Weight | Get Alert |
| 02/24/2023 | Buy Now | 7.78% | Baird | Jeff Johnson77% | $340 → $350 | Maintains | Outperform | Get Alert |
| 01/26/2023 | Buy Now | — | Wolfe Research | Mike Polark67% | — | Initiates | → Peer Perform | Get Alert |
| 01/06/2023 | Buy Now | -1.46% | Morgan Stanley | Cecilia Furlong51% | $300 → $320 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | -7.62% | Morgan Stanley | David Lewis71% | $273 → $300 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | -3% | Baird | Jeff Johnson77% | $300 → $315 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | -1.46% | Raymond James | Jayson Bedford68% | $280 → $320 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | 4.7% | Piper Sandler | Matt O'Brien52% | $235 → $340 | Upgrade | Neutral → Overweight | Get Alert |
| 10/18/2022 | Buy Now | -26.71% | Barclays | Matt Miksic67% | → $238 | Initiates | → Equal-Weight | Get Alert |
| 10/12/2022 | Buy Now | -19.94% | Jefferies | Matthew Taylor69% | → $260 | Initiates | → Hold | Get Alert |
| 08/22/2022 | Buy Now | -4.54% | TD Cowen | Josh Jennings61% | → $310 | Maintains | Outperform | Get Alert |
| 08/08/2022 | Buy Now | -15.94% | Morgan Stanley | David Lewis71% | $244 → $273 | Maintains | Equal-Weight | Get Alert |
| 08/05/2022 | Buy Now | -10.7% | Canaccord Genuity | Kyle Rose68% | $250 → $290 | Maintains | Buy | Get Alert |
| 08/05/2022 | Buy Now | -7.62% | Baird | Jeff Johnson77% | $245 → $300 | Maintains | Outperform | Get Alert |
| 08/05/2022 | Buy Now | -13.78% | Raymond James | Jayson Bedford68% | $262 → $280 | Maintains | Outperform | Get Alert |
| 08/05/2022 | Buy Now | -27.64% | Piper Sandler | Matt O'Brien52% | $230 → $235 | Maintains | Neutral | Get Alert |
| 07/11/2022 | Buy Now | -23.02% | Citigroup | Joanne Wuensch75% | $310 → $250 | Downgrade | Buy → Neutral | Get Alert |
| 06/24/2022 | Buy Now | -23.02% | BTIG | Marie Thibault66% | $310 → $250 | Maintains | Buy | Get Alert |
| 06/07/2022 | Buy Now | -24.87% | Morgan Stanley | David Lewis71% | $268 → $244 | Maintains | Equal-Weight | Get Alert |
| 05/17/2022 | Buy Now | -4.54% | Citigroup | Joanne Wuensch75% | $350 → $310 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Insulet (PODD) stock?
The latest price target for Insulet (NASDAQ:PODD) was reported by Wolfe Research on May 13, 2025. The analyst firm set a price target for $350.00 expecting PODD to rise to within 12 months (a possible 7.78% upside). 31 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Insulet (PODD)?
The latest analyst rating for Insulet (NASDAQ:PODD) was provided by Wolfe Research, and Insulet upgraded their outperform rating.
When was the last upgrade for Insulet (PODD)?
The last upgrade for Insulet Corp happened on May 13, 2025 when Wolfe Research raised their price target to $350. Wolfe Research previously had a peer perform for Insulet Corp.
When was the last downgrade for Insulet (PODD)?
The last downgrade for Insulet Corp happened on April 29, 2025 when Wolfe Research changed their price target from N/A to N/A for Insulet Corp.
When is the next analyst rating going to be posted or updated for Insulet (PODD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Insulet, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Insulet was filed on May 13, 2025 so you should expect the next rating to be made available sometime around May 13, 2026.
Is the Analyst Rating Insulet (PODD) correct?
While ratings are subjective and will change, the latest Insulet (PODD) rating was a upgraded with a price target of $0.00 to $350.00. The current price Insulet (PODD) is trading at is $324.75, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
